XML 119 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net Income per Share
6 Months Ended
Jun. 30, 2013
Earnings Per Share [Abstract]  
Net (Loss) Income per Share
Net Loss per Share
The following is a reconciliation of net income and weighted-average common shares outstanding for purposes of calculating diluted net loss per share for the three and six months ended June 30, 2013 and 2012:
(in millions, except per share amounts)
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
 
2013
 
2012
 
2013
 
2012
Net loss
 
$
(19.2
)
 
$
(14.8
)
 
$
(18.3
)
 
$
(13.7
)
Basic weighted-average number of shares outstanding
 
171.1

 
168.2

 
170.4

 
168.1

Effect of dilutive securities
 
 
 
 
 
 
 
 
Common stock purchase warrants
 
—

 
—

 
—

 
—

Share-based awards
 
—

 
—

 
—

 
—

Prepaid common stock purchase contracts
 
—

 
—

 
—

 
—

Diluted weighted-average number of shares outstanding
 
171.1

 
168.2

 
170.4

 
168.1

Net loss per share
 
 
 
 
 
 
 
 
Basic
 
$
(0.11
)
 
$
(0.09
)
 
$
(0.11
)
 
$
(0.08
)
Diluted
 
$
(0.11
)
 
$
(0.09
)
 
$
(0.11
)
 
$
(0.08
)

For the three and six months ended June 30, 2013, approximately 2.6 million and 2.3 million, respectively, of options and 1.5 million of PSUs were excluded from the computation of diluted weighted-average shares as the exercise prices exceeded the price of the common stock. For the three and six months ended June 30, 2013, approximately 1.2 million and 0.2 million, respectively, of RSUs were excluded from the computation of diluted weighted-average shares as the effect would have been anti-dilutive under the treasury stock method. The issuance of 44.9 million shares for the settlement of the tMEDS purchase contracts were considered in the calculation of diluted weighted-average shares; however, due to the net loss position of the Company, they have not been reflected above as they would be anti-dilutive.
For the three and six months ended June 30, 2012, approximately 2.5 million stock options and 0.9 million PSUs were excluded from the computation of diluted weighted-average shares as the exercise prices exceeded the average price of TCM's common stock for the period.